Clinical Trial Update: JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC） [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for JS001sc or JS001 with chemotherapy in relapsed or metastatic non-squamous non-small cell lung cancer; the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• JS001 (PD-1 inhibitor)
• JS001sc

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING